Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kimberlee Kris Gauvreau, Sc.D.

Co-Author

This page shows the publications co-authored by Kimberlee Gauvreau and Sarah De Ferranti.
Connection Strength

1.445
  1. Improving Cardiovascular Health in a Pediatric Preventive Cardiology Practice. J Pediatr. 2021 05; 232:282-286.e1.
    View in: PubMed
    Score: 0.240
  2. The relationship between payer type and lipid outcomes in response to clinical lifestyle interventions in youth with dyslipidemia. BMC Pediatr. 2019 07 02; 19(1):217.
    View in: PubMed
    Score: 0.215
  3. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018 12 01; 172(12):e183310.
    View in: PubMed
    Score: 0.206
  4. Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr. 2009 Jun; 154(6):901-5.
    View in: PubMed
    Score: 0.105
  5. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem. 2006 Jul; 52(7):1325-30.
    View in: PubMed
    Score: 0.086
  6. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004 Oct 19; 110(16):2494-7.
    View in: PubMed
    Score: 0.077
  7. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology. 2004 Jun; 100(6):1345-52.
    View in: PubMed
    Score: 0.075
  8. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis. CJC Open. 2021 Jul; 3(7):880-887.
    View in: PubMed
    Score: 0.060
  9. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3.
    View in: PubMed
    Score: 0.060
  10. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis. Arch Dis Child. 2021 03; 106(3):247-252.
    View in: PubMed
    Score: 0.058
  11. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease. J Pediatr. 2019 09; 212:87-92.
    View in: PubMed
    Score: 0.054
  12. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population. J Am Heart Assoc. 2019 06 04; 8(11):e011319.
    View in: PubMed
    Score: 0.053
  13. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis. Pediatrics. 2019 06; 143(6).
    View in: PubMed
    Score: 0.053
  14. Impact of Treatment Modality on Vascular Function in Coarctation of the Aorta: The LOVE - COARCT Study. J Am Heart Assoc. 2019 04 02; 8(7):e011536.
    View in: PubMed
    Score: 0.053
  15. Rationale and design of Long-term Outcomes and Vascular Evaluation after Successful Coarctation of the Aorta Treatment study. Ann Pediatr Cardiol. 2018 Sep-Dec; 11(3):282-296.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.